US EditionPublished • loading... • Updated
Experimental vaccine shows early signs of benefit in Parkinson’s
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Experimental vaccine shows early signs of benefit in Parkinson’s
ACI-7104, an experimental vaccine being tested in people with early-stage Parkinson’s disease, has been generally well tolerated and is showing early signals that it may slow disease progression, according to interim Phase 2 data from its developer, AC Immune. “The interim Phase 2 data shows the potential of our [ACI-7104] active immunotherapy to slow the progression of Parkinson’s disease and hold the promise of a tremendous step forward for mi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
